NCT06872099View on ClinicalTrials.gov

NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized Children

RecruitingOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

November 6, 2021

Primary Completion Date

February 19, 2025

Study Completion Date

March 19, 2025

Conditions
NAsal MEthicillin-resistant Staphylococcus
Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, SC Malattie Infettive 1, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER